Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Director Kimberly H. Johnson acquired 11 shares of Eli Lilly common stock through a deferral plan, at a price of $885.01 per share.

Summary

• Kimberly H. Johnson, a director at Eli Lilly & Co, acquired 11 shares of common stock on June 17, 2024.
• The shares were acquired at a price of $885.01 each.
• These shares were obtained through the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The shares will be settled in common stock after Ms. Johnson's separation from service.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, a director acquiring shares through a deferral plan, which is generally viewed positively as it indicates confidence in the company. There are no negative implications.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

Director share acquisitions are a common occurrence in publicly traded companies and are often seen as a sign of confidence in the company's future performance.

Comparison to Industry Standards

• Director share acquisitions are a standard practice across publicly listed companies.
• The use of deferral plans for director compensation is also a common practice.
• The price of $885.01 per share reflects the market value of Eli Lilly stock at the time of the transaction.

Stakeholder Impact

• The share acquisition by a director may be viewed positively by shareholders as it indicates confidence in the company's future.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Units, LLY, Kimberly H. Johnson